'Public-private partnership important in Indian GM crop regime'

Image
IANS Kolkata
Last Updated : May 21 2015 | 10:42 PM IST

India cannot totally depend on the public sector for development of genetically modified (GM) products to feed its large population, said noted crop scientist Swapan Datta, stressing that the private companies have to play a role.

Datta, an eminent scientist associated with the Golden Rice project and former deputy director general (crop sciences) at the Indian Council for Agricultural Research, vouched for public-private partnership for joint development and ownership of GM food crop products.

"The government needs to take a long term vision for a practical solution. Big questions will be asked if private players come into the picture but participation of indigenous private sector is needed to encourage the GM crop regime in the country," Datta, the current pro vice chancellor of Visva Bharati University, said here during a media workshop "Communicating Science and Biosafety" on Thursday.

The workshop was organised by Indian Institute of Mass Communication in collaboration with University of Calcutta's department of journalism and mass communication.

Debunking myths about potential harmful effects of GM crops, such as Bt Brinjal, which was commercially released in Bangladesh recently, Datta said: "China is doing it (commercializing GM crops) as we debate and discuss."

Since GM products are almost entirely from multinational companies because Indian seed companies are smaller in terms of their R&D expenditure, this also affects public confidence, particularly among farmers, he said.

"When China realized the value of the application of biotechnology and GM foods, they started putting in money like anything... they put in around $2 to 3 billion a year in transgenic work. China wants to compete with multinationals with work but India wants to compete with multinationals without work. That's the fundamental difference," he said.

As an example of deadlocks, Datta cited the case of Bt Brinjal.

In India, the Genetic Engineering Approval Committee (GEAC) had approved commercial cultivation of Bt brinjal in 2009, but the then Environment Minister Jairam Ramesh, put an indefinite moratorium on the decision.

"For 100 years no adverse effects of Bt gene have been found scientifically but still we are wasting taxpayers's money on monitoring and conducting safety studies," said Datta, who was a member of the GEAC that pushed for introduction of Bt Brinjal.

Currently, Bt cotton is the only GM crop allowed for commercial production in India.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 21 2015 | 9:38 PM IST

Next Story